← 返回

卵巢癌免疫治疗的视觉分析:2010 年至 2025 年的文献计量学分析

英文原题:Visual analysis of ovarian cancer immunotherapy: a bibliometric analysis from 2010 to 2025.

查看英文原题

Visual analysis of ovarian cancer immunotherapy: a bibliometric analysis from 2010 to 2025.

PubMed 2025/07/11(内容时间) Front Med (Lausanne) Q1 · IF 3.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

卵巢癌免疫治疗研究进展迅速,利用免疫系统对抗肿瘤已成为癌症治疗的前沿。本文旨在从文献计量学角度探讨卵巢癌免疫治疗的前景与发展趋势。从 Web of Science Core Collection(WoSCC)中检索有关肿瘤负荷与免疫治疗的文献(检索日期为2025年5月1日)。使用 R 包 "Bibliometrics" 分析关键文献计量学特征,并构建三字段图以展示机构、国家和关键词之间的关系。使用 VOSviewer 进行共作者分析、共现分析及可视化。使用 CiteSpace 计算引用突现和关键词。共检索到15年科学研究中的1,449篇文献。中国和美国(US)发表的文章最多。发文量最多的期刊是 Cancer Immunology Immunotherapy 和 Journal for Immunotherapy of Cancer。发文量最高的机构是 HARVARD UNIVERSITY。近年来,引用突现强度较高的热点关键词为 "dendritic cells"、"monoclonal antibody" 和 "adoptive immunotherapy"。本文献计量学分析绘制了基本的知识结构。肿瘤负荷与免疫治疗领域正进入快速增长阶段,并在未来研究中持续保持其价值。

展开英文摘要原文

Research on immunotherapy for ovarian cancer is rapidly advancing, and harnessing the immune system to fight tumors is at the forefront of cancer treatment. This article aims to discuss the prospect and development trend of immunotherapy for ovarian cancer from the perspective of bibliometrics. Articles about tumor burden and immunotherapy were collected from the Web of Science Core Collection (WoSCC) (retrieved on 1 May 2025). R package "Bibliometrics" analyzes key bibliometric characteristics and creates a three-filed map to show the relationships between institutions, countries, and keywords. VOSviewer is used for co-author analysis, co-occurrence analysis, and visualization.

CiteSpace calculates citation burst citations and keywords. A total of 1,449 publications were retrieved from 15 years of scientific research. The China and United States (US) published the most articles. The most productive journals were Cancer Immunology Immunotherapy and Journal for Immunotherapy of Cancer. The top institution with the highest output was HARVARD UNIVERSITY.

In recent years, the hot keywords of strong citation burst strength were "dendritic cells," "monoclonal antibody," and "adoptive immunotherapy." This bibliometric analysis mapped a basic knowledge structure. The tumor burden and immunotherapy field is entering a rapidly growing stage and keeping its value for future research.

论文信息

作者
Zhang Y、Chen Y、Chen C、Cheng X、Peng Y、Wang J、Li F、Wenting L
单位
First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, China.China
文献类型
综述
期刊
Frontiers in medicine2025
原文标识
PubMed 40718421 · DOI 10.3389/fmed.2025.1573512